Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery

NCT02334007 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism
Lung Neoplasms
Pulmonary Embolism

Interventions

DRUG: LMWH: Dalteparin
OTHER: Placebo

Sponsor

McMaster University